Organ Care System (OCS) Lung System
TransMedics, Inc. · Decision date Mar 22, 2018
What did the FDA approve?
The FDA database entry for PMA number P160013 records an approval decision dated March 22, 2018, for the Organ Care System (OCS) Lung System from TransMedics, Inc. The approval statement describes the device as indicated for preserving standard criteria donor lungs in a near physiologic, ventilated, and perfused state for double lung transplantation.
The device category field identifies the product as a normothermic machine perfusion system for the preservation of standard criteria donor lungs prior to transplantation. The product code is QBA. The entry does not include a supplement type or supplement reason, so no information about a changed item or original scope beyond the approval statement is present in the supplied fields.
FDA approval order statement
Approval for the OCS Lung System, indicated for the preservation of standard criteria donor lungs in a near physiologic, ventilated, and perfused state for double lung transplantation.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Mar 22, 2018
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160013
- Regulatory pathway
- Premarket approval application
- Applicant
- TransMedics, Inc.
- Product code
- QBA
- Decision code
- APPR
- Decision date
- Mar 22, 2018
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Normothermic machine perfusion system for the preservation of standard criteria donor lungs prior to transplantation.
- Applicant
- TransMedics, Inc.
- Product code
- QBA
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P160013 received
Application receipt date recorded by FDA.
P160013 · FDA decision
APPR
P160013/S023 · Related supplement
Organ Care System (OCS) Lung System
Timeline entries are records held by MedtechLedger for P160013. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160013
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Organ Care System (OCS) Lung SystemP160013/S023 | TransMedics, Inc. | PMA supplement | Oct 28, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
TransMedics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 200 Minuteman Rd., Suite 302, Andover, MA, 01810
Sources and methodology
- Original FDA record: P160013
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records